AGAcell® on "20 minutos": A Spanish stem cell study brings the end of alopecia closer.

A Spanish stem cell study brings the end of alopecia closer.

A study conducted by the Department of Dermatology at Hospital Clínico San Carlos in Madrid has become a beacon of hope for people seeking to overcome or prevent alopecia, according to an article published in the journal Stem Cell Research & Therapy.

The key to the success of the research, led by the Head of Dermatology at the Madrid hospital, Dr. Eduardo López Bran, lies in the combination of stem cells derived from body fat with an energizing molecule—adenosine triphosphate (ATP)—described as a kind of "battery" that powers the stem cells.

According to Dr. López Bran, the end of baldness in both men and women is now closer than ever, although it may still take up to five years to become a reality, pending the next phases of clinical trials, human testing, and regulatory approvals. Specifically, Dr. López Bran and his team are focused on addressing androgenetic alopecia, the most common form of hair loss.